The Valvular Interventions Center

Filter Your Results




NaviGate's Transcatheter Tricuspid Valved Stent Successfully Implanted in a Compassionate-Use Procedure

May 5, 2017 -- NaviGate Cardiac Structures Inc. (NCSI) recently announced the first successful implantation of the company's Gate catheter-guided tricuspid atrioventr…

VIVID Registry Compares Transcatheter Valves for Treating Failing Aortic Surgical Bioprostheses

May 1, 2017 -- Findings from the Valve-in-Valve International Data (VIVID) Registry were published by Sami Alnasser, MD, et al online ahead of print in Circulation: Cardi…

Thirty-Day and 1-Year Outcomes Published From PARTNER 2 Valve-in-Valve Registry

May 1, 2017 -- The 30-day and 1-year outcomes in a large cohort of high-risk patients undergoing valve-in-valve (VIV) transcatheter aortic valve replacement (TAVR) in the PART…

Venus Medtech's Venus A-Valve TAVR Device Approved in China

April 28, 2017 -- Venus Medtech (Hangzhou) Inc. announced that its Venus A-valve transcatheter aortic valve replacement (TAVR) system has been approved by the China Food and D…

Analysis of Swiss Registry Compares Medtronic's Evolut R With Earlier-Generation CoreValve TAVR Prosthesis

April 17, 2017 -- Findings from an analysis of the Swiss TAVI Registry were published by Stephane Noble, MD, et al in the online e-edition of a href="…

Aortic Valves: What’s Coming?

Thomas Modine, MD, PhD, MBA; Darren Mylotte, MD; and Nicolo Piazza, MD, PhD

March/April 2017—Devices in early clinical development, including devices with early human experience and those originating from China.

The Equivalence of SAVR and TAVR

Andrew Roy, MD, FESC; Dinesh Natarajan, MBBS, BMedSci; and Bernard Prendergast, BMedSci, BM BS, MRCP, DM, FRCP, FESC

March/April 2017—Potential pitfalls as the use of TAVR is extended to low- and intermediate-risk patients.

Ask the Experts: What Is Your Institution’s Approach to CAD in TAVR Patients?

With Lowell Satler, MD; Toby Rogers, MD, PhD; Jubin Joseph, MA, BMBCh; Simon R. Redwood, MD; Giuliana Capretti, MD; Alaide Chieffo, MD; and Antonio Colombo, MD

March/April 2017—Several institutions share their methods for treating patients with coronary artery disease who undergo transcatheter aortic valve replacement.



2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007, with its launch issue focusing on the state of coronary drug-eluting stent use. Each edition will cover a variety of topics in a flexible format that includes articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's cardiology practices.